Myocardial alpha-thrombin receptor activation induces hypertrophy and increases atrial natriuretic factor gene

C C Glembotski1, C E Irons, K A Krown

  • 1Department of Biology, San Diego State University, California 92182.

Insights

Alpha-thrombin (alpha Th) stimulates cardiac myocyte growth and gene expression via specific receptors. This process involves protein kinase C and tyrosine kinases, suggesting extracellular proteases regulate heart cell function.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Protease Signaling

Background:

  • Alpha-thrombin (alpha Th) influences myocardial contractility, a characteristic of hypertrophy-inducing agents.
  • The presence of alpha Th receptors (alpha Th-R) on cardiac myocytes and alpha Th's long-term effects on cell growth and gene expression remain uncharacterized.

Purpose of the Study:

  • To investigate whether cardiac myocytes express alpha Th receptors.
  • To determine if long-term alpha Th treatment enhances myocyte growth and gene expression.
  • To elucidate the signaling pathways involved in alpha Th-induced cardiac myocyte hypertrophy and gene regulation.

Main Methods:

  • Primary neonatal rat ventricular myocytes were analyzed for alpha Th-R mRNA expression using a specific probe.
  • Cells were treated with alpha Th, alpha Th-R agonist/non-agonist peptides, and specific inhibitors (protease, PKC, tyrosine kinase inhibitors).
  • Hypertrophy, sarcomeric organization, and atrial natriuretic factor (ANF) expression were assessed; transcriptional activity was confirmed via transfection experiments.

Main Results:

  • Neonatal rat ventricular myocytes express a 3.6-kb mRNA for alpha Th-R.
  • Alpha Th induced myocyte hypertrophy, sarcomeric organization, and enhanced ANF expression, which were blocked by a specific protease inhibitor.
  • An alpha Th-R agonist peptide activated ANF expression, while a non-agonist peptide did not; inhibition studies revealed the involvement of protein kinase C and tyrosine kinases.

Conclusions:

  • Cardiac myocytes possess functional alpha Th receptors that mediate the effects of alpha Th.
  • Alpha Th-induced myocyte hypertrophy and ANF expression are dependent on protein kinase C and tyrosine kinase signaling pathways.
  • Extracellular proteases like alpha Th represent novel regulators of myocardial cell gene expression and growth.

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...